Why Isn’t There a Cure for Headache Disorders?

You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!


Key Questions
  • What prompted you to write a book about headache disorders?
  • What impact do you hope your book will have?
  • When did your cluster headaches begin?
  • How did you manage your attacks while working in a high-pressure newsroom?
  • Does the invisible nature of headache increase its toll on those who experience it?
  • Does the medical profession take headache disorders as seriously as they deserve?
  • What was your lowest point in your experience of living with cluster headaches?
  • What was the most surprising thing you learned while researching your book?
  • What gives you hope for those who experience headache disorders?
Interview Notes
Treatments Mentioned
  • Capsaicin
  • CGRP monoclonal antibodies (mAbs)
  • Magnesium
  • Neuromodulation devices
  • Steroids
  • Sumatriptan
  • Verapamil

Find 300+ treatments in our full Treatment Directory — available with a VIP Access Pass.


For additional links and resources, click here.

Disclaimer: The Migraine World Summit aims to bring you a variety of perspectives and expertise, free from bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan. Captions are auto-generated and may contain errors.

photo of a man with black and gray hair beard and mustache and glasses

Tom Zeller Jr.

Author | Editor-In-Chief
The Headache | Undark

Tom Zeller Jr. is an American journalist, former New York Times reporter and columnist, and current editor-in-chief of the digital science magazine Undark.

He is the author of the 2025 book The Headache: The Science of a Most Confounding Affliction, and a Search for Relief as well as a co-editor and contributing author of the 2022 book, A Tactical Guide to Science Journalism, published by Oxford University Press.

He is co-editor and a contributing author of the 2022 book, A Tactical Guide to Science Journalism, published by Oxford University Press.

In 2013, Tom was awarded a Knight Science Journalism Fellowship at MIT, where he spent a year studying environmental decision-making, economics, and climate policy — topics he has covered in the United States and abroad for Al Jazeera America, as well as The Times, National Geographic, Bloomberg View, Forbes, and other publications.

He co-founded Undark in 2016. Under his leadership, the magazine’s work has been anthologized in the Best American Science & Nature Writing book series, and honored with numerous awards and accolades, including the Al Neuharth Innovation in Investigative Journalism Award and the prestigious George Polk Award for Environmental Reporting. Undark has also been named a finalist for a National Magazine Award, and earned top prizes from the Society of Environmental Journalists, the Association of Health Care Journalists, the National Association of Science Writers, and the Online News Association.

Go Beyond the Free Summit Interviews

  • Full-length expert interviews beyond the 30-minute edits
  • Revisit any 2026 session anytime
  • Transcripts and audio downloads included
  • Review insights before medical appointments
Get Full Summit Access

Related Talks for: Day 8 (2026)

Small, Sustainable Lifestyle Changes To Help Minimize Migraine

Rebecca Erwin Wells, MD, MPH, FAHS, FAAN

Told You’re “Out of Options”? There’s Hope

Lauren R. Natbony, MD, FAHS

CGRP, PACAP & Beyond: The Future of Migraine Relief

Messoud Ashina, MD, PhD, DMSc

The Migraine Association of Ireland is a Patient Orientated Organisation, Providing Information and Support for People That Suffer with Migraine, in an Overlooked Environment.

Learn more

View more/less

Amneal is a U.S. based biopharmaceutical company elevating the standard of care for patients in hard-to-treat and under-served conditions. We are expanding access to safe, effective, and innovative Specialty medicines across neurology, including migraine, with a focus on pairing high-quality medicines with the resources healthcare providers need to support patient care. We work with healthcare teams across the country to ensure providers have the tools to prescribe with confidence and patients have access to the medicines they need.

Learn more

View more/less

Today is the final day to get the Summit discount. Upgrade now to keep the interviews, revisit the expert insights anytime, and go deeper with extended sessions and additional resources. Your purchase also helps support our nonprofit partners.

View more/less
Loading...